Josh and Jason return to podcasting and discuss the recently released New England Journal paper on remdesivir for Covid-19.Links for this episode:<ul data-rte-list="default"><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2007764">Remdesivir for the Treatment of Covid-19 — Preliminary Report</a></li><li><a href="https://twitter.com/NEJM/status/1263953448682348550">NEJM tweet when the paper was released</a></li><li><a href="https://www.niaid.nih.gov/news-events/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19">NIH press release on April 29th</a></li><li><a href="https://youtu.be/EMZzYsQwTUQ">Mark Denison giving a talk on his work with coronaviruses and remdesivir</a></li><li><a href="https://www.nytimes.com/2020/05/22/opinion/coronavirus-treatment-mild-symptoms.html">Treating Mild Coronavirus Cases Could Help Save Everyone | NY Times</a></li></ul>Have a question or comment? Drop us a line on our <a href="http://www.medi.io/connect">feedback form</a> or send <a href="https://twitter.com/JoshHerigon">Josh</a> or <a href="https://twitter.com/JasonGNewland">Jason</a> a tweet.<a href="https://podcasts.apple.com/us/podcast/001-were-back/id815344580?i=1000475720043">Listen on Apple Podcasts</a><img src="https://feedpress.me/link/5648/13570760.gif" height="1" width="1"/>

002: One health

Weekly podcast hosted by Josh Herigon discussing the intersection of medicine, technology, social media, and design